Quoin Pharmaceuticals (QNRX) Non-Current Assets (2017 - 2026)

Quoin Pharmaceuticals has disclosed Non-Current Assets across 10 years of filings, most recently posting $333334.0 for Q2 2026.

• In Q2 2026, Non-Current Assets fell 23.08% year-over-year to $333334.0; the TTM figure through Jun 2026 stood at $1.5 million (down 42.21% YoY), while the FY2025 annual figure was $383334.0, down 51.06% from the prior year.
• Non-Current Assets came in at $333334.0 for Q2 2026 at Quoin Pharmaceuticals, down from $358334.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.1 million in Q4 2022 to a low of $333334.0 in Q2 2026.
• Average Non-Current Assets over 5 years is $724974.6, with a median of $806583.0 recorded in 2022.
• Year-over-year, Non-Current Assets rose 28.43% in 2023 and sank 54.21% in 2025.
• Over 5 years, Non-Current Assets stood at $1.1 million in 2022, then slipped by 18.81% to $883334.0 in 2023, then slipped by 11.32% to $783334.0 in 2024, then sank by 51.06% to $383334.0 in 2025, then retreated by 13.04% to $333334.0 in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $333334.0 in Q2 2026, $358334.0 in Q1 2026, and $383334.0 in Q4 2025.